Versant Ventures VI GP, L.P., 10% Owner at Monte Rosa Therapeutics, Inc. (GLUE), bought 2,097,938 shares at $19.00 ($3.0M) on 2021-06-28, disclosed to the SEC on 2021-06-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,940,043 | $0 | 0.0% |
| 2 | $19.00 | 157,895 | $3.0M | 100.0% |
| Total | $1.43 avg | 2,097,938 | $3.0M | 100% |
| Filing → |
| AKRO | SELL | 2020-07-10 | $2.1M | — | Filing → |
| PASG | BUY | 2020-03-03 | $4.0M | — | Filing → |